Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133638) titled 'A Study on the Optimization of Tacrolimus Dosage Strategies for Hematopoietic Stem Cell Transplant Patients Using Machine Learning' on Sept. 29.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Zhejiang Provincial People's Hospital
Condition:
Such as blood system disorders like acute lymphoblastic leukemia and aplastic anemia.
Intervention:
Intervention group:A machine learning-based prediction model for adjusting the dose of tacrolimus (TAC) enables dynamic adjustment of this drug's dosage.
control groups:Adjustment of doses based on the experience of routine clinicians
Recruitment...